| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 127, 1287-1291, Copyright © 1990 by Endocrine Society
ARTICLES |
L Lim, SA Spencer, P McKay and MJ Waters
Department of Physiology and Pharmacology, University of Queensland, St. Lucia, Australia.
The in vitro biological effects of serum GH-binding protein (GHBP) were measured in the mouse 3T3-F442A preadipocyte adipogenesis assay during GH stimulation. Coincubation of increasing concentrations of human (h) GH (0.14-4.5 nM) with 4.2 nM recombinant hGHBP-(1-247) in serum-free medium shifted the hGH dose-response curve to the right over the range 0.14-0.9 nM. When the hGH concentration was fixed at 0.45 nM, a dose- dependent inhibition of GH bioactivity was seen over the range of 0.1- 11.3 nM GHBP, with an ED50 of 3 nM. The presence of serum had no effect on the inhibitory properties of GHBP. When 2% pooled human serum was added to incubation medium containing 0.45 nM hGH and GHBP (0.6 nM-5.7 nM), the effect of GHBP was again inhibitory, with an ED50 of 1.2 nM. Two percent serum alone was adipogenic, but at this low serum concentration it is likely that some factor other than GH is responsible. In a homologous receptor assay, the binding of [125I]hGH to IM-9 lymphocytes was inhibited in a dose-dependent manner by increasing concentrations of hGHBP in the physiological range, providing further support for the idea that GHBP can regulate the bioactivity of GH by blocking the binding of free GH to target tissues in vivo. Our results suggest that one function of GHBP is to dampen the biological effects of pulsatile GH secretion by reducing free GH during secretory pulses. This effect combined with an increased half-life of circulating GH would have the effect of flattening the hormone secretory profile at the target tissue level.
This article has been cited by other articles:
![]() |
M. Kawai, N. Namba, S. Mushiake, Y. Etani, R. Nishimura, M. Makishima, and K. Ozono Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPAR{gamma} pathway J. Mol. Endocrinol., January 1, 2007; 38(1): 19 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho Estrogen Regulation of Growth Hormone Action Endocr. Rev., October 1, 2004; 25(5): 693 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Edmondson, S. P. Thumiger, G. A. Werther, and C. J. Wraight Epidermal Homeostasis: The Role of the Growth Hormone and Insulin-Like Growth Factor Systems Endocr. Rev., December 1, 2003; 24(6): 737 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, K. He, M. Gerhart, J. Jiang, R. J. Paxton, R. K. Menon, R. A. Black, G. Baumann, and S. J. Frank Reduced Proteolysis of Rabbit Growth Hormone (GH) Receptor Substituted with Mouse GH Receptor Cleavage Site Mol. Endocrinol., October 1, 2003; 17(10): 1931 - 1943. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Graichen, J. Sandstedt, E. L. K. Goh, O. G. P. Isaksson, J. Tornell, and P. E. Lobie The Growth Hormone-binding Protein Is a Location-dependent Cytokine Receptor Transcriptional Enhancer J. Biol. Chem., February 14, 2003; 278(8): 6346 - 6354. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wolthers, D. M. Hoffman, A. G. Nugent, M. W Duncan, M. Umpleby, and K. K. Y. Ho Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1191 - E1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-A. Bengtsson and G. Johannsson The Treatment of Growth Hormone Deficiency in Adults J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 933 - 937. [Full Text] |
||||
![]() |
L. Rui, S. F. Archer, L. S. Argetsinger, and C. Carter-Su Platelet-derived Growth Factor and Lysophosphatidic Acid Inhibit Growth Hormone Binding and Signaling via a Protein Kinase C-dependent Pathway J. Biol. Chem., January 28, 2000; 275(4): 2885 - 2892. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Leung, N. Doyle, and K. K. Y. Ho Characterization of a Low Affinity Binding Protein for Growth Hormone in Rat Serum Endocrinology, January 1, 2000; 141(1): 138 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Edens and F. Talamantes Alternative Processing of Growth Hormone Receptor Transcripts Endocr. Rev., October 1, 1998; 19(5): 559 - 582. [Abstract] [Full Text] |
||||
![]() |
G. P. Frick, L.-R. Tai, W. R. Baumbach, and H. M. Goodman Tissue Distribution, Turnover, and Glycosylation of the Long and Short Growth Hormone Receptor Isoforms in Rat Tissues Endocrinology, June 1, 1998; 139(6): 2824 - 2830. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Alele, J. Jiang, J. F. Goldsmith, X. Yang, H. G. Maheshwari, R. A. Black, G. Baumann, and S. J. Frank Blockade of Growth Hormone Receptor Shedding by a Metalloprotease Inhibitor Endocrinology, April 1, 1998; 139(4): 1927 - 1935. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Leung and K. K. Y. Ho Stimulation of Mitochondrial Fatty Acid Oxidation by Growth Hormone in Human Fibroblasts J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4208 - 4213. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tzanela, C. Wagner, and G. Shaffer Tannenbaum Recombinant Human Growth Hormone-Binding Protein Fails to Enhance the in Vivo Bioactivity of Human Growth Hormone in Normal Rats Endocrinology, December 1, 1997; 138(12): 5316 - 5324. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Amit, T. Bergman, F. Dastot, M. B. H. Youdim, S. Amselem, and Z.'e. Hochberg A Membrane-Fixed, Truncated Isoform of the Human Growth Hormone Receptor J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3813 - 3817. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Ymer, J. L. Stevenson, and A. C. Herington Guinea Pig Serum Contains a Specific High Affinity Growth Hormone-Binding Protein with Novel Ligand Specificity Endocrinology, September 1, 1997; 138(9): 3577 - 3586. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tonshoff, M. J. Cronin, M. Reichert, D. Haffner, A.-M. Wingen, W. F. Blum, and O. Mehls Reduced Concentration of Serum Growth Hormone (GH)-Binding Protein in Children with Chronic Renal Failure: Correlation with GH Insensitivity J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1007 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fisker, N. Vahl, J. O. L. Jorgensen, J. S. Christiansen, and H. Orskov Abdominal Fat Determines Growth Hormone-Binding Protein Levels in Healthy Nonobese Adults J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 123 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Kline and C. V. Clevenger Identification and Characterization of the Prolactin-binding Protein in Human Serum and Milk J. Biol. Chem., June 29, 2001; 276(27): 24760 - 24766. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, R. Guan, J. Jiang, J. J. Kopchick, R. A. Black, G. Baumann, and S. J. Frank Growth Hormone (GH)-induced Dimerization Inhibits Phorbol Ester-stimulated GH Receptor Proteolysis J. Biol. Chem., June 29, 2001; 276(27): 24565 - 24573. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |